Data gathered: October 28
Alternative Data for Doximity
About Doximity
Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, case collaboration and messaging capabilities.
| Price | $68.50 |
| Target Price | Sign up |
| Volume | 1,750,000 |
| Market Cap | $12.5B |
| Year Range | $50.71 - $76.68 |
| Dividend Yield | 0% |
| PE Ratio | 57.13 |
| Analyst Rating | 31% buy |
| Earnings Date | November 6 '25 |
| Industry | Digital health |
In the news
![]() |
Doximity (DOCS) Shares Skyrocket, What You Need To KnowOctober 27 - Yahoo |
![]() |
Doximity just upgraded at BofA, here's whyOctober 27 - Thefly.com |
![]() |
Doximity's Platform to Benefit From Advertisers' Shift to Healthcare Provider Channel, BofA SaysOctober 27 - Yahoo |
B of A Securities Upgrades Doximity (DOCS)October 26 - Fintel |
|
![]() |
Doximity, Commvault, Samsara, Cloudflare, and Okta Stocks Trade Down, What You Need To KnowOctober 22 - Yahoo |
![]() |
How the Narrative Around Doximity Is Shifting With New Analyst Views and AI DevelopmentsOctober 18 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '25 | 146M | 16M | 130M | 53M | 67M | 0.360 |
| Q1 '25 | 138M | 14M | 124M | 62M | 52M | 0.380 |
| Q4 '24 | 169M | 14M | 154M | 75M | 83M | 0.450 |
| Q3 '24 | 137M | 14M | 123M | 44M | 58M | 0.300 |
| Q2 '24 | 127M | 14M | 113M | 41M | 49M | 0.280 |
Insider Transactions View All
| Benjamin Regina M. filed to sell 19,839 shares at $70.8. October 14 '25 |
| Wampler Kira Scherer filed to sell 19,839 shares at $70. October 3 '25 |
| Cabral Timothy S filed to sell 3,221 shares at $75. September 26 '25 |
| Benjamin Regina M. filed to sell 19,839 shares at $70.5. September 16 '25 |
| Cabral Timothy S filed to sell 3,221 shares at $66.3. September 4 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
![]() |
Teladoc HealthTDOC |
$9.01 0% | 53 |
![]() |
Veeva SystemsVEEV |
$295.69 0% | 57 |
![]() |
GoodRxGDRX |
$3.77 0% | 37 |
![]() |
Lifestance HealthLFST |
$5.11 0% | 33 |
![]() |
AmwellAMWL |
$5.52 0% | 41 |
Read more about Doximity (DOCS) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, app downloads, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Doximity?
The Market Cap of Doximity is $12.5B.
What is Doximity's PE Ratio?
As of today, Doximity's PE (Price to Earnings) ratio is 57.13.
When does Doximity report earnings?
Doximity will report its next earnings on November 6 '25.
What is the current stock price of Doximity?
Currently, the price of one share of Doximity stock is $68.50.
How can I analyze the DOCS stock price chart for investment decisions?
The DOCS stock price chart above provides a comprehensive visual representation of Doximity's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Doximity shares. Our platform offers an up-to-date DOCS stock price chart, along with technical data analysis and alternative data insights.
Does DOCS offer dividends to its shareholders?
As of our latest update, Doximity (DOCS) does not offer dividends to its shareholders. Investors interested in Doximity should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Doximity?
Some of the similar stocks of Doximity are Teladoc Health, Veeva Systems, GoodRx, Lifestance Health, and Amwell.
.







